US Bancorp
CGON icon

US Bancorp’s CG Oncology CGON Stock Holding History

US Bancorp’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.5K Buy
643
+36
+6% +$2.04K ﹤0.01% 2776
2025
Q4 		$25.2K Hold
607
– – ﹤0.01% 2992
2025
Q3 		$24.4K Sell
607
-21
-3% -$611 ﹤0.01% 2986
2025
Q2 		$16.3K Buy
628
+415
+195% +$10K ﹤0.01% 3246
2025
Q1 		$5.22K Buy
213
+123
+137% +$3.46K ﹤0.01% 3644
2024
Q4 		$2.58K Sell
90
-14
-13% -$479 ﹤0.01% 3807
2024
Q3 		$3.92K Sell
104
-172
-62% -$6.03K ﹤0.01% 3646
2024
Q2 		$8.71K Buy
+276
New +$9.57K ﹤0.01% 3360

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM